FREDUN PHARMACEUTICALS
Back to Balance Sheet
|
FREDUN PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹327 Cr | ₹167 Cr | ₹140 Cr | ₹74 Cr | ₹86 Cr |
What is the latest Total Current Liabilities ratio of FREDUN PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹327 Cr |
| Mar2024 | ₹167 Cr |
| Mar2023 | ₹140 Cr |
| Mar2022 | ₹74 Cr |
| Mar2021 | ₹86 Cr |
How is Total Current Liabilities of FREDUN PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹327 Cr | 96.20 | |
| Mar2024 | ₹167 Cr | 19.46 | |
| Mar2023 | ₹140 Cr | 89.36 | |
| Mar2022 | ₹74 Cr | -14.70 | |
| Mar2021 | ₹86 Cr | - | |
Compare Total Current Liabilities of peers of FREDUN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FREDUN PHARMACEUTICALS | ₹885.7 Cr | -1.5% | 10.1% | 138.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,185.0 Cr | 3.5% | 12.3% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,766.0 Cr | 2.8% | 7.2% | 7.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,923.0 Cr | 3.8% | 12.1% | 42.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,081.0 Cr | 3% | 9.1% | 11.6% | Stock Analytics | |
| CIPLA | ₹109,680.0 Cr | 1.2% | 2.8% | -9.1% | Stock Analytics | |
FREDUN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FREDUN PHARMACEUTICALS | -1.5% |
10.1% |
138.7% |
| SENSEX | -0.3% |
-0.1% |
8.3% |
You may also like the below Video Courses